RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Loyda M. Meléndez to Cannabinoids

This is a "connection" page, showing publications Loyda M. Meléndez has written about Cannabinoids.
Connection Strength

0.802
  1. Rosario-Rodr?guez LJ, Gerena Y, Garc?a-Requena LA, Cartagena-Isern LJ, Cuadrado-Ruiz JC, Borges-V?lez G, Mel?ndez LM. Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages. Sci Rep. 2022 01 07; 12(1):233.
    View in: PubMed
    Score: 0.802
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support